NeoStem Announces Very Small Embryonic-Like Cells Publication in Stem Cells and Development

NeoStem, Inc. (NYSE MKT:NBS), an emerging leader in the fast growing cell therapy market, announced today that data from its collaborative studies with the University of Michigan School of Dentistry further expands the therapeutic potential of its proprietary regenerative cell therapy product, "VSELS^TM" (very small embryonic-like stem cells), by demonstrating bone regeneration capabilities in a study published online ahead of print^1 in the journal Stem Cells and Development (DOI: 10.1089/scd.2012.0327). The paper highlights that human VSEL stem cells form human bone when implanted in the bone tissue of SCID mice.